More than 30 years of domestic and international experience in the discovery, development, registration, and commercialization of chemical and biotechnology products.
Executive leadership roles with Acumen Pharmaceuticals, Mendel Biotechnology and Monsanto, managing corporate and commercial development, negotiating contracts, drafting and executing business plans, developing intellectual property protection strategies, building and leading high performance teams.
International experience in market analyses, product development, regulatory and public acceptance, and commercialization.
Author of two published pharmacological research articles related to Alzheimer's Disease and the holder of eight patents or patent applications.
CEO, COO, chief business officer/business vice president. Also technology leadership in an organization, which could be the Chief Scientific Officer or director of research and development programs.
Investors, board members, senior leadership team, research and development, legal department.
Startup, early stage, and emerging biotechnology companies; life sciences including pharmaceutical and agricultural biotechnology.
One to 250 employees.